DIAGNOS Announces Private Placement

BROSSARD, Quebec, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSXV:ADK, OTCQB:DGNOF, FWB: 4D4A)), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces a non-brokered private placement ("Private placement") of 10 units (each a "Unit") to be issued at a price of $10,000 per Unit for gross proceeds of $100,000.

Each Unit consists of:

 

(i)

One $10,000 unsecured convertible debenture (each a "Debenture"), and